As of December 31, 2025, CELLBXHEALTH PLC carries a market capitalization of 19.54M, placing it among publicly traded companies globally. Its enterprise value stands at 12.09M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 19.54M |
| Enterprise Value | 12.09M |
CELLBXHEALTH PLC 's next confirmed earnings release is scheduled for April 29, 2027.
| Earnings Date | 4/29/2027 |
As of December 31, 2025, CELLBXHEALTH PLC has 1.14B shares outstanding.
| Shares Outstanding | 1.14B |
These figures are as of December 31, 2025.
| PB Ratio | 2.02 |
| P/TBV Ratio | 2.13 |
As of December 31, 2025, CELLBXHEALTH PLC maintains a current ratio of 2.76, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.76 |
| Quick Ratio | 1.95 |
| Debt / Equity | 25.25 |
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 81.50 |
As of the close on October 22, 2026, CELLBXHEALTH PLC 's stock has declined approximately 60.80% over the past 52 weeks.
| 52-Week Price Change | -60.80% |
As of December 31, 2025, CELLBXHEALTH PLC holds 9.90M in cash and equivalents against 2.45M in total debt, resulting in a net debt position of -9.90M. Total book value stands at 9.70M, with working capital of 8.92M providing operational flexibility.
| Cash & Cash Equivalents | 9.90M |
| Total Debt | 2.45M |
| Net Debt | -9.90M |
| Equity (Book Value) | 9.70M |
| Book Value Per Share | 0.01 |
| Working Capital | 8.92M |
CELLBXHEALTH PLC 's most recent stock split took place on June 6, 2024.
| Last Split Date | 6/6/2024 |
Already premium?